Relmada Therapeutics (RLMD) null Earnings

15MayConfirmed
Sep 16
Nov 16
Feb 17
May 17
-1.68
-1.18
-0.67
-0.17

Details

Expected EPS
N/A
Actual EPS
-0.6585
Surprise EPS
-0.66
Surprise Percent
+∞%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.6585 per share for .

0 Comments

Share your thoughts